Member Info for Hurst10

Hope you all are on board, they will not let us down.
Have a good Week End everybody, enjoy the evening.
Almost 17.00, marvellous.

Not Guinness please!
But agree

I keep coming across all these studies, featuring Affimer and battling obesity.Huge market and very profitable, ask Novo!

Post hours size order

We will make new 52week highs this week and then break out.
Pleased you are beginning to understand what size buying means.Price has no relevance, holding has!
Get an up to date share holder list and you will be surprised what the effective US shareholder holding is, incl convertible bond issue.
Just had ASCO conference in the US.
More news flow coming our way.
Watch this afternoon.

Perhaps very upbeat news from AVA3396 is due much sooner than we expect.
Will remind us of the potential value of the AVA family and which would coming up to the Science day maje it a severe wake up call for the buy side, accelerate size buying and Nasdaq knocking on the door.

Size buyer stepping in ??

Remember cash or shares:
offering of convertible bonds of £55 million in aggregate principal amount with an issue price of 95 per cent. of the principal amount (resulting in gross cash proceeds of £52.25m) to be issued by its wholly-owned subsidiary Addition Finance (Jersey) Limited, with 6.5 per cent. per annum coupon (payable quarterly in cash or shares at the Company’s option) and an initial 25 per cent.

Sorry if repeat:

GenScript ProBio expanding again.
Avacta?s JV Affyxell will be watching
Ready to expand, GenScript raises $224M for CDMO focused on antibodies, cell and gene therapies.
https://endpts.com/genscript-probio-cdmo-manufacturer-cell-gene-therapies-224m/

Rather amusing reading your comment,I can imagine being a day trader must be frustrating, as the person you make the money is the broker.
However if you do your research in a stock and the sector, you will find the best strategy in Avacta for quite some time, have been never to sell, take advantage of days when the market got it wrong and just pick up more stock.+ 60% since November.
We are looking at one of the most undervalued stocks on London stock exchange, post JPM conference the M&A activity in Precision medicine and Gene therapy have picked up significantly and you day traders will find it very difficult, as you will also have the “ danger” of the next price moving RNS, which will move the price into a new trading range.Watch the volume now 05.00AM NY, they are not concerned about the price, they just want their holding filled, before “ the event”.
Keep buying. Good luck

Remember Novartis disposed of their stake in Roche, now planning spinoff of Sandoz, this is what their opening comments was at their recent presentation at JP Morgan:
Today, I have the opportunity to – I'm sorry, have to go back here, to really introduce the company in its next form as a pure-play innovative medicines company. Because with the planned spin of Sandoz, for the first time in our history, we will really be a focused company with a focused strategy, and we believe that's a strategy that can create sustained value for shareholders, and importantly – more importantly, sustained value for patients, healthcare and of course, all of the stakeholders that we serve.

Now our vision is to become the most valued and trusted medicines company in the world. That's a long-term vision. Of course, visions like this take decades to form. But that's what animates our organization, gives our organization energy, the relentless pursuit of this goal. And what we've rolled out inside of the company is a focused strategy, one where we really thought hard about where do we want to play and how do we want to win. And our focus now is on five core therapeutic areas, which I'll speak a little bit more about in a moment, five technology platforms; two that you know well, small molecules and biologics; and three, advanced technology platforms that we've been working on now for many years; four, priority geographies that we think will ultimately enable us to grow for the long-term.

Do we have an itinerary ?

With similar volume Thursday and Friday, we could have could have the market stepping up a gear and push the price further up.

Meanwhile we are moving higher, sure you mean well, but whether you like it or not, share price will continue to going north, overseas size buyers present and more news flow to come.
Buy!!!

Let us see this week !

We’re up 50% since Christmas
Just wait for the precision oncology bid!!!
160-5 opening
Watch the bid

210-5 by Saturday
Ava portfolio will strike

170-5 pre NY tomorrow

Good size post market prints at 155.50.

Pls, you make us laugh.
The price is moving and will continue to do so.
Size buyers since December have enjoyed a 50% increase and a similar rise will take place again pre science day.
Happy investors indeed.